Ionis Pharmaceuticals competitorsClear all

Ionis Pharmaceuticals's top competitors include Arrowhead Pharmaceuticals, Alnylam Pharmaceuticals, Regulus Therapeutics and Inositec.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals discovers and develops RNA-targeted therapeutics.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Inositec
Inositec
Inositec is a company developing treatments for soft tissue calcification disorders.
Founding Date
Founding Date
1989
Founding Date
2004
Founding Date
2002
Founding Date
2007
Founding Date
2015
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Carlsbad, US HQ
Locations
Pasadena, US HQ
Madison, US
Locations
Cambridge, US HQ
Paris, FR
Milano, IT
Amsterdam, NL
Stockholm, SE
Zug, CH
Maidenhead, GB
Locations
San Diego, US HQ
Locations
Zürich, CH HQ
Employees
Employees
81711% increase
Employees
13416% increase
Employees
1,32324% increase
Employees
2462% decrease
Employees
6
Valuation ($)
Valuation ($)
7.1 b
Valuation ($)
7 b
Valuation ($)
14.4 b
Valuation ($)
23.5 m
Valuation ($)
N/A
Twitter followers
Twitter followers
3 k
Twitter followers
2.4 k
Twitter followers
13.4 k
Twitter followers
783
Twitter followers
46
Number of tweets (last 30 days)
Number of tweets (last 30 days)
27
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
41
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
7.7
Average likes per tweet (last 30 days)
35.4
Average likes per tweet (last 30 days)
8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
259972
Alexa Website Rank
235448
Alexa Website Rank
294228
Alexa Website Rank
269443
Alexa Website Rank
N/A
Employee Rating
Employee Rating
3.3
Employee Rating
N/A
Employee Rating
4
Employee Rating
3
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$1.1b (FY, 2019)
Revenue (est.)
$168.8m (FY, 2019)
Revenue (est.)
$219.8m (FY, 2019)
Revenue (est.)
$6.8m (FY, 2019)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$4.4m (FY, 2019)
Cost of goods
N/A
Cost of goods
$25.1m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$1.1b (FY, 2019)
Gross profit
N/A
Gross profit
$194.7m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
$294.1m (FY, 2019)
Net income
$68m (FY, 2019)
Net income
($886.1m) (FY, 2019)
Net income
($18.6m) (FY, 2019)
Net income
N/A

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
359 (FY, 2016)
Patents Issued
N/A
Patents Issued
300 (FY, 2016)
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 201.3m
Total funding raised
$ 147.1m
Total funding raised
$ 1.5b
Total funding raised
$ 10m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Arrowhead Pharmaceuticals
HQ
Pasadena, US
Employees
134↑ 16% increase

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Inositec
HQ
Zürich, CH
Employees
6

Inositec is a company developing treatments for soft tissue calcification disorders.

View company